Polar Capital Holdings Plc 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 09:26 am Sale | 2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Polar Capital Holdings Plc | 6,297,688 6.670% | -820,256 (-11.52%) | Filing |
| 2023-11-16 1:13 pm Purchase | 2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Polar Capital Holdings Plc | 7,117,944 7.560% | 7,117,944 (New Position) | Filing |